Castle Biosciences Future Growth
Future criteria checks 1/6
Castle Biosciences is forecast to grow earnings and revenue by 34.9% and 9.3% per annum respectively. EPS is expected to grow by 36.5% per annum. Return on equity is forecast to be -11.6% in 3 years.
Key information
34.9%
Earnings growth rate
36.5%
EPS growth rate
| Healthcare earnings growth | 15.7% |
| Revenue growth rate | 9.3% |
| Future return on equity | -11.6% |
| Analyst coverage | Good |
| Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
Investors Appear Satisfied With Castle Biosciences, Inc.'s (NASDAQ:CSTL) Prospects
Jan 27
Castle Biosciences (NASDAQ:CSTL) Is In A Good Position To Deliver On Growth Plans
Oct 31Earnings Working Against Castle Biosciences, Inc.'s (NASDAQ:CSTL) Share Price Following 36% Dive
Jun 13Analysts Just Published A Bright New Outlook For Castle Biosciences, Inc.'s (NASDAQ:CSTL)
Aug 14Castle Biosciences Q2 2022 Earnings Preview
Aug 08Is There Now An Opportunity In Castle Biosciences, Inc. (NASDAQ:CSTL)?
Aug 05Estimating The Intrinsic Value Of Castle Biosciences, Inc. (NASDAQ:CSTL)
Jun 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 290 | -32 | 19 | 29 | 4 |
| 12/31/2025 | 257 | -56 | 1 | 10 | 9 |
| 12/31/2024 | 238 | -62 | -7 | 13 | 9 |
| 12/31/2023 | 220 | -57 | -19 | -6 | N/A |
| 9/30/2023 | 192 | -76 | -42 | -30 | N/A |
| 6/30/2023 | 168 | -89 | -52 | -40 | N/A |
| 3/31/2023 | 152 | -72 | -54 | -46 | N/A |
| 12/31/2022 | 137 | -67 | -47 | -42 | N/A |
| 9/30/2022 | 124 | -53 | -43 | -38 | N/A |
| 6/30/2022 | 110 | -44 | -43 | -39 | N/A |
| 3/31/2022 | 98 | -52 | -40 | -37 | N/A |
| 12/31/2021 | 94 | -31 | -22 | -19 | N/A |
| 9/30/2021 | 86 | -30 | -20 | -17 | N/A |
| 6/30/2021 | 78 | -23 | -18 | -13 | N/A |
| 3/31/2021 | 68 | -15 | 1 | 6 | N/A |
| 12/31/2020 | 63 | -10 | 5 | 10 | N/A |
| 9/30/2020 | 63 | -3 | 10 | 15 | N/A |
| 6/30/2020 | 63 | 7 | 16 | 18 | N/A |
| 3/31/2020 | 61 | 6 | 4 | 5 | N/A |
| 12/31/2019 | 52 | 3 | 6 | 7 | N/A |
| 9/30/2019 | 46 | 4 | -1 | -1 | N/A |
| 6/30/2019 | 35 | -6 | -4 | -3 | N/A |
| 3/31/2019 | 28 | -8 | -9 | -8 | N/A |
| 12/31/2018 | 23 | -10 | -13 | -12 | N/A |
| 12/31/2017 | 41 | -46 | -38 | -37 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CSTL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CSTL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CSTL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CSTL's revenue (9.3% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: CSTL's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CSTL is forecast to be unprofitable in 3 years.